Samogidenta - Company finances
|
EUR
|
2022
From: 2022-04-08
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 6,325 | 26,310 | 22,440 | 28,565 |
| Profit before tax | 3,057 | 2,376 | 1,158 | 2,077 |
| Net profit | 3,057 | 2,247 | 1,072 | 1,949 |
| Equity | 3,157 | 5,404 | 4,676 | 6,625 |
| Liabilities | 2,188 | 923 | 322 | 596 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 5,345 | 6,327 | 4,998 | 7,221 |
| Total assets | 5,345 | 6,327 | 4,998 | 7,221 |
|
Taxes paid
|
||||
| STI taxes | - | - | 168 | 93 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +316.0% | -14.7% | +27.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 57.2% | 35.5% | 21.4% | 27.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 96.8% | 41.6% | 22.9% | 29.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 48.3% | 8.5% | 4.8% | 6.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 48.3% | 9.0% | 5.2% | 7.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.2 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Samogidenta - Social security debts
The amount of overdue SODRA debt for the company Samogidenta as of the last working day is: 80 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 80.48 |
| 2026-09-01 | 2026-09-02 | 80.48 |
| 2026-08-23 | 2026-08-23 | 80.48 |
| 2026-08-19 | 2026-08-19 | 80.48 |
| 2026-08-16 | 2026-08-17 | 80.48 |
| 2026-08-05 | 2026-08-14 | 80.48 |
| 2026-08-01 | 2026-08-04 | 249.20 |
| 2026-07-30 | 2026-07-31 | 168.72 |
| 2026-07-01 | 2026-07-29 | 241.07 |
| 2026-06-02 | 2026-06-30 | 160.59 |
| 2026-05-03 | 2026-06-01 | 80.11 |
| 2025-03-03 | 2025-03-31 | 7.58 |
| 2025-02-01 | 2025-02-28 | 7.58 |
| 2024-02-08 | 2024-02-29 | 5.87 |
| 2024-02-01 | 2024-02-07 | 64.50 |
| 2024-01-03 | 2024-01-31 | 58.63 |
| 2023-12-01 | 2023-12-31 | 58.63 |
| 2023-10-03 | 2023-10-31 | 58.63 |
| 2023-09-01 | 2023-09-30 | 117.26 |
| 2023-07-03 | 2023-08-31 | 58.63 |
| 2023-06-01 | 2023-06-30 | 117.26 |
| 2023-05-04 | 2023-05-31 | 58.63 |
| 2023-04-03 | 2023-04-30 | 58.63 |
| 2023-03-01 | 2023-03-31 | 58.58 |
| 2023-01-03 | 2023-01-31 | 101.90 |
| 2022-12-01 | 2023-01-02 | 50.95 |
Samogidenta - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Samogidenta is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-22 | 2026-09-02 | 0.12 |
| 2026-02-27 | 2026-04-26 | 0.1 |
| 2026-02-21 | 2026-02-26 | 13.1 |
| 2025-06-23 | 2026-02-20 | 0.1 |
| 2025-06-19 | 2025-06-21 | 93.08 |
| 2025-02-20 | 2025-06-18 | 7.08 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Samogidenta, MB (code 306060295) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €28.6K and net profit of €1.9K, with a profit margin of 6.8%. Revenue increased by 27.3% year on year, while the two-year change was +8.6%, showing a recovery after the weaker 2024 result. The revenue path over the last three years was €26.3K in 2023, €22.4K in 2024 and €28.6K in 2025. Net profit followed a similar pattern, moving from €2.2K in 2023 to €1.1K in 2024 and back to €1.9K in 2025. At the end of 2025, total assets were €7.2K, equity €6.6K and liabilities €596, leaving a high equity ratio of 91.8%. Debt remained low, with debt-to-equity at 0.09. Asset turnover was 3.96x, indicating efficient use of the asset base, while ROE was 29.4% and ROA 27.0% in 2025.